We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Blackbaud
BLKB
$1.94B
| $6K | ﹤0.01% |
+105
| New | +$5.84K |
|
1402
CNX Resources
CNX
$5.3B
| $6K | ﹤0.01% |
+551
| New | +$5.55K |
|
1403
Commault Systems
CVLT
$4.88B
| $6K | ﹤0.01% |
+114
| New | +$5.33K |
|
1404
ENI
E
$80.5B
| $6K | ﹤0.01% |
+304
| New | +$5.5K |
|
1405
EnerSys
ENS
$6.78B
| $6K | ﹤0.01% |
+72
| New | +$5.65K |
|
1406
Equinor
EQNR
$97.7B
| $6K | ﹤0.01% |
+378
| New | +$5.72K |
|
1407
FirstCash
FCFS
$8.85B
| $6K | ﹤0.01% |
+92
| New | +$5.83K |
|
1408
First Solar
FSLR
$22.7B
| $6K | ﹤0.01% |
+57
| New | +$4.94K |
|
1409
GoDaddy
GDDY
$11B
| $6K | ﹤0.01% |
+77
| New | +$6.05K |
|
1410
ArcelorMittal
MT
$52.9B
| $6K | ﹤0.01% |
+243
| New | +$4.25K |
|
1411
Murphy Oil
MUR
$5.7B
| $6K | ﹤0.01% |
+506
| New | +$5.03K |
|
1412
Park Aerospace
PKE
$737M
| $6K | ﹤0.01% |
+481
| New | +$5.92K |
|
1413
Qiagen
QGEN
$8.54B
| $6K | ﹤0.01% |
+100
| New | +$5.34K |
|
1414
LiveRamp
RAMP
$2.3B
| $6K | ﹤0.01% |
+82
| New | +$5.23K |
|
1415
Reynolds Consumer Products
REYN
$5.26B
| $6K | ﹤0.01% |
+207
| New | +$6.26K |
|
1416
RH
RH
$3.13B
| $6K | ﹤0.01% |
+13
| New | +$5.36K |
|
1417
Roku
ROKU
$21.5B
| $6K | ﹤0.01% |
+17
| New | +$4.46K |
|
1418
Rayonier
RYN
$6.55B
| $6K | ﹤0.01% |
+239
| New | +$6.1K |
|
1419
Terex
TEX
$7.18B
| $6K | ﹤0.01% |
+184
| New | +$5.43K |
|
1420
Tredegar Corp
TG
$265M
| $6K | ﹤0.01% |
+354
| New | +$5.95K |
|
1421
Wolfspeed
WOLF
$1.23B
| $6K | ﹤0.01% |
+54
| New | +$4.34K |
|
|
WW
1422
DELISTED
WW International
WW
| $6K | ﹤0.01% |
+227
| New | +$5.9K |
|
|
X
1423
DELISTED
US Steel
X
| $6K | ﹤0.01% |
+361
| New | +$4.49K |
|
|
CNH
1424
CNH Industrial
CNH
$12.7B
| $6K | ﹤0.01% |
+535
| New | +$4.66K |
|
|
CAJ
1425
DELISTED
Canon, Inc.
CAJ
| $6K | ﹤0.01% |
+305
| New | +$5.5K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.